{"id":110296,"date":"2026-06-17T00:00:00","date_gmt":"2026-06-17T00:00:00","guid":{"rendered":"https:\/\/enterpriseam.com\/ksa\/?p=110296"},"modified":"2026-06-17T02:58:35","modified_gmt":"2026-06-17T02:58:35","slug":"biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand","status":"publish","type":"post","link":"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/","title":{"rendered":"Biotech firms weigh up listings and takeovers amid fierce demand"},"content":{"rendered":"

Biotech firms are sitting on a rare double exit windo<\/strong>w<\/strong> \u2014 IPO markets and major pharma acquirers are both competing for the same assets, JPMorgan EMEA healthcare investment banking co-heads Juha Anjala and Roy Wouters told CNBC<\/a>. <\/p>\n

By the numbers: <\/strong>Biotech dealmaking has already hit USD 106 bn from 21 transactions this year, CNBC<\/a> reports elsewhere, after 2025 saw seven transactions each worth USD 5-15 bn. That puts it on track for its strongest year since its pre-pandemic peak seven years ago. <\/p>\n

Why the frenzy: <\/strong>Pharma firms are racing against a patent cliff \u2014 when a blockbuster drug's exclusivity expires, generics flood the market and revenues can collapse by 80-90% almost overnight. A wave of those expirations is coming simultaneously, with analysts estimating a sector-wide revenue hit of up to USD 350 bn by 2032. Buying proven biotech assets is the fastest way to replace that pipeline \u2014 around half of the best-performing drugs in recent years were acquired rather than developed in-house, with the most competition clustering around metabolic conditions, infectious diseases, and oncology.<\/p>\n

The result:<\/strong> The strongest performers are keeping both options open simultaneously \u2014 prepping for an IPO while fielding acquisition conversations. Some are choosing the takeover route outright.<\/p>\n

GCC sovereign wealth is also circling. <\/strong>Abu Dhabi\u2019s Mubadala has been expanding its presence in the biotech sector through its pharma unit arm Mubadala Bio with investments in the US\u2019 ElectraTherapeutics<\/a> and nutri-tech firm L-Nutra<\/a>, while the Abu Dhabi Investment Authority has been similarly active<\/a>. Qatar has a sizable biotech investment footprint, with a USD 250 mn play into BridgeBio Pharma<\/a> and USD 255 mn for Isotope Technologies Munich<\/a>.<\/p>\n

MARKETS THIS MORNING- <\/p>\n

Asia-Pacific markets are mixed in early trading this morning <\/strong>as the rally sparked by the US-Iran framework agreement cools and investors sit tight ahead of today\u2019s Federal Reserve policy decision. Japan\u2019s Nikkei is up 0.7%, while South Korea\u2019s Kospi is down 0.1%. Over on Wall Street, equities are set to open higher, with futures in the green.<\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

<\/use><\/svg><\/p>\n<\/td>\n\n

TASI<\/strong><\/p>\n<\/td>\n

\n

11,146<\/p>\n<\/td>\n

\n

+0.5% (YTD: +6.2%)<\/p>\n<\/td>\n<\/tr>\n

\n

<\/use><\/svg><\/p>\n<\/td>\n\n

MSCI Tadawul 30<\/strong><\/p>\n<\/td>\n

\n

1,489<\/p>\n<\/td>\n

\n

+0.6% (YTD: +7.3%)<\/p>\n<\/td>\n<\/tr>\n

\n

<\/use><\/svg><\/p>\n<\/td>\n\n

NomuC<\/strong><\/p>\n<\/td>\n

\n

23,221<\/p>\n<\/td>\n

\n

+1.0% (YTD: -0.3%)<\/p>\n<\/td>\n<\/tr>\n

\n

<\/use><\/svg><\/p>\n<\/td>\n\n

USD : SAR (SAMA)<\/strong><\/p>\n<\/td>\n

\n

USD 3.75 Sell<\/p>\n<\/td>\n

\n

USD 3.75 Buy<\/p>\n<\/td>\n<\/tr>\n

\n

<\/use><\/svg><\/p>\n<\/td>\n\n

Interest rates<\/strong><\/p>\n<\/td>\n

\n

4.25% repo <\/p>\n<\/td>\n

\n

3.75% reverse repo<\/p>\n<\/td>\n<\/tr>\n

\n

<\/use><\/svg><\/p>\n<\/td>\n\n

EGX30<\/strong> <\/p>\n<\/td>\n

\n

52,047<\/p>\n<\/td>\n

\n

-0.5% (YTD: +24.4%)<\/p>\n<\/td>\n<\/tr>\n

\n

<\/use><\/svg><\/p>\n<\/td>\n\n

ADX<\/strong><\/p>\n<\/td>\n

\n

9,936<\/p>\n<\/td>\n

\n

+1.6% (YTD: -0.3%)<\/p>\n<\/td>\n<\/tr>\n

\n

<\/use><\/svg><\/p>\n<\/td>\n\n

DFM<\/strong><\/p>\n<\/td>\n

\n

6,055<\/p>\n<\/td>\n

\n

+1.7% (YTD: +0.1%)<\/p>\n<\/td>\n<\/tr>\n

\n

<\/use><\/svg><\/p>\n<\/td>\n\n

S&P 500<\/strong><\/p>\n<\/td>\n

\n

7,511<\/p>\n<\/td>\n

\n

-0.6% (YTD: +9.7%)<\/p>\n<\/td>\n<\/tr>\n

\n

<\/use><\/svg><\/p>\n<\/td>\n\n

FTSE 100<\/strong><\/p>\n<\/td>\n

\n

10,494<\/p>\n<\/td>\n

\n

+0.6% (YTD: +5.7%)<\/p>\n<\/td>\n<\/tr>\n

\n

<\/use><\/svg><\/p>\n<\/td>\n\n

Euro Stoxx 50<\/strong><\/p>\n<\/td>\n

\n

6,257<\/p>\n<\/td>\n

\n

+0.5% (YTD: +8.0%)<\/p>\n<\/td>\n<\/tr>\n

\n

<\/use><\/svg><\/p>\n<\/td>\n\n

Brent crude<\/strong><\/p>\n<\/td>\n

\n

USD 79.48<\/p>\n<\/td>\n

\n

-4.4%<\/p>\n<\/td>\n<\/tr>\n

\n

<\/use><\/svg><\/p>\n<\/td>\n\n

Natural gas <\/strong>(Nymex)<\/p>\n<\/td>\n

\n

USD 3.24<\/p>\n<\/td>\n

\n

+2.9%<\/p>\n<\/td>\n<\/tr>\n

\n

<\/use><\/svg><\/p>\n<\/td>\n\n

Gold<\/strong><\/p>\n<\/td>\n

\n

USD 4,354<\/p>\n<\/td>\n

\n

+0.1%<\/p>\n<\/td>\n<\/tr>\n

\n

<\/use><\/svg><\/p>\n<\/td>\n\n

BTC<\/strong><\/p>\n<\/td>\n

\n

USD 65,713<\/p>\n<\/td>\n

\n

-1.0% (YTD: -25.0%)<\/p>\n<\/td>\n<\/tr>\n

\n

<\/use><\/svg><\/p>\n<\/td>\n\n

Sukuk\/bond market index<\/strong><\/p>\n<\/td>\n

\n

914.20<\/p>\n<\/td>\n

\n

+0.1% (YTD: -0.6%)<\/p>\n<\/td>\n<\/tr>\n

\n

<\/use><\/svg><\/p>\n<\/td>\n\n

S&P MENA Bond & Sukuk<\/strong><\/p>\n<\/td>\n

\n

152.49<\/p>\n<\/td>\n

\n

+0.3% (YTD: +0.4%)<\/p>\n<\/td>\n<\/tr>\n

\n

<\/use><\/svg><\/p>\n<\/td>\n\n

VIX (Volatility Index)<\/strong><\/p>\n<\/td>\n

\n

16.22<\/p>\n<\/td>\n

\n

+0.1% (YTD: +8.4%)<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n

\n

THE CLOSING BELL: TADAWUL-<\/p>\n

The TASI <\/strong>rose 0.5% yesterday on turnover of SAR 4.7bn. The index is up 6.2% YTD.<\/p>\n

In the green:<\/strong> Tadco (+5.8%), Bupa Arabia (+5.2%), and Development Works Food (+4.8%).<\/p>\n

In the red: <\/strong>Saudi Cable (-4.5%), Budget Saudi (-2.8%), and Nice One (-2.5%).<\/p>\n

\n

THE CLOSING BELL: NOMU-<\/p>\n

The NomuC<\/strong> rose 1.0% yesterday on turnover of SAR 15 mn. The index is down 0.3% YTD.<\/p>\n

In the green:<\/strong> Anmat (+11.6%), Fadeco (+9.8%), and Riyal Investment (+9.2%).<\/p>\n

In the red:<\/strong> Naf (-9.8%), Paper Home (-8.3%), and Mufeed (-7.5%).<\/p>\n","protected":false},"excerpt":{"rendered":"

Biotech dealmaking is picking up as firms look to get ahead of an incoming patent deadline<\/p>\n","protected":false},"author":1,"featured_media":110297,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"newspack_ads_suppress_ads":false,"newspack_popups_has_disabled_popups":false,"newspack_sponsor_sponsorship_scope":"","newspack_sponsor_native_byline_display":"inherit","newspack_sponsor_native_category_display":"inherit","newspack_sponsor_underwriter_style":"inherit","newspack_sponsor_underwriter_placement":"inherit","ep_exclude_from_search":false,"_primary_brand":0,"newspack_featured_image_position":"","newspack_post_subtitle":"","newspack_article_summary_title":"Overview:","newspack_article_summary":"","newspack_hide_updated_date":false,"newspack_show_updated_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[2565],"tags":[4591,10,55,2637,2720,2636,59],"brand":[],"newspack_spnsrs_tax":[],"class_list":["post-110296","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-planet-finance","tag-biotech","tag-enterpriseam-ksa","tag-financial-markets","tag-ipo","tag-ma","tag-pharma","tag-planet-finance","wpautop","entry"],"acf":{"mongo_id":"a6340c78-8dee-4237-9166-bc1c3a416dc1","order":"11","is_powered_by":false,"story_type":"1","photo_url":"https:\/\/ent.news\/2026\/6\/977.jpg","photo_position":"above","homepage_title":"","full_issue_title":"It\u2019s a good time to be a biotech","related_issue":[110277],"teaser":"Biotech dealmaking is picking up as firms look to get ahead of an incoming patent deadline"},"yoast_head":"\nBiotech firms weigh up listings and takeovers amid fierce demand - KSA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biotech firms weigh up listings and takeovers amid fierce demand\" \/>\n<meta property=\"og:description\" content=\"Biotech dealmaking is picking up as firms look to get ahead of an incoming patent deadline\" \/>\n<meta property=\"og:url\" content=\"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/\" \/>\n<meta property=\"og:site_name\" content=\"KSA\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-17T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-17T02:58:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i0.wp.com\/ent.news\/2026\/6\/977.jpg?fit=%2C&ssl=1\" \/>\n<meta name=\"author\" content=\"enterpriseam admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"enterpriseam admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/\"},\"author\":{\"name\":\"enterpriseam admin\",\"@id\":\"https:\/\/enterpriseam.com\/ksa\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\"},\"headline\":\"Biotech firms weigh up listings and takeovers amid fierce demand\",\"datePublished\":\"2026-06-17T00:00:00+00:00\",\"dateModified\":\"2026-06-17T02:58:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/\"},\"wordCount\":480,\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/ksa\/#organization\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/ent.news\/2026\/6\/977.jpg?fit=%2C&ssl=1\",\"keywords\":[\"biotech\",\"EnterpriseAM KSA\",\"Financial markets\",\"IPO\",\"M&A\",\"pharma\",\"PLANET FINANCE\"],\"articleSection\":[\"PLANET FINANCE\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/\",\"url\":\"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/\",\"name\":\"Biotech firms weigh up listings and takeovers amid fierce demand - KSA\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/ksa\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/ent.news\/2026\/6\/977.jpg?fit=%2C&ssl=1\",\"datePublished\":\"2026-06-17T00:00:00+00:00\",\"dateModified\":\"2026-06-17T02:58:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/#primaryimage\",\"url\":\"https:\/\/i0.wp.com\/ent.news\/2026\/6\/977.jpg?fit=%2C&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/ent.news\/2026\/6\/977.jpg?fit=%2C&ssl=1\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/enterpriseam.com\/ksa\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biotech firms weigh up listings and takeovers amid fierce demand\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/enterpriseam.com\/ksa\/#website\",\"url\":\"https:\/\/enterpriseam.com\/ksa\/\",\"name\":\"KSA\",\"description\":\"The State of the Nation\",\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/ksa\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/enterpriseam.com\/ksa\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/enterpriseam.com\/ksa\/#organization\",\"name\":\"KSA\",\"url\":\"https:\/\/enterpriseam.com\/ksa\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/ksa\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ent.news\/internal\/42482.svg\",\"contentUrl\":\"https:\/\/ent.news\/internal\/42482.svg\",\"caption\":\"KSA\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/ksa\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/enterpriseam.com\/ksa\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\",\"name\":\"enterpriseam admin\",\"sameAs\":[\"http:\/\/enterpriseam.testing.projectsarea.com\"],\"url\":\"https:\/\/enterpriseam.com\/ksa\/author\/enterpriseam\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Biotech firms weigh up listings and takeovers amid fierce demand - KSA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/","og_locale":"en_US","og_type":"article","og_title":"Biotech firms weigh up listings and takeovers amid fierce demand","og_description":"Biotech dealmaking is picking up as firms look to get ahead of an incoming patent deadline","og_url":"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/","og_site_name":"KSA","article_published_time":"2026-06-17T00:00:00+00:00","article_modified_time":"2026-06-17T02:58:35+00:00","og_image":[{"url":"https:\/\/i0.wp.com\/ent.news\/2026\/6\/977.jpg?fit=%2C&ssl=1","type":"","width":"","height":""}],"author":"enterpriseam admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"enterpriseam admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/#article","isPartOf":{"@id":"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/"},"author":{"name":"enterpriseam admin","@id":"https:\/\/enterpriseam.com\/ksa\/#\/schema\/person\/ca597032db7e4db868359c123cec256d"},"headline":"Biotech firms weigh up listings and takeovers amid fierce demand","datePublished":"2026-06-17T00:00:00+00:00","dateModified":"2026-06-17T02:58:35+00:00","mainEntityOfPage":{"@id":"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/"},"wordCount":480,"publisher":{"@id":"https:\/\/enterpriseam.com\/ksa\/#organization"},"image":{"@id":"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/ent.news\/2026\/6\/977.jpg?fit=%2C&ssl=1","keywords":["biotech","EnterpriseAM KSA","Financial markets","IPO","M&A","pharma","PLANET FINANCE"],"articleSection":["PLANET FINANCE"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/","url":"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/","name":"Biotech firms weigh up listings and takeovers amid fierce demand - KSA","isPartOf":{"@id":"https:\/\/enterpriseam.com\/ksa\/#website"},"primaryImageOfPage":{"@id":"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/#primaryimage"},"image":{"@id":"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/ent.news\/2026\/6\/977.jpg?fit=%2C&ssl=1","datePublished":"2026-06-17T00:00:00+00:00","dateModified":"2026-06-17T02:58:35+00:00","breadcrumb":{"@id":"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/#primaryimage","url":"https:\/\/i0.wp.com\/ent.news\/2026\/6\/977.jpg?fit=%2C&ssl=1","contentUrl":"https:\/\/i0.wp.com\/ent.news\/2026\/6\/977.jpg?fit=%2C&ssl=1"},{"@type":"BreadcrumbList","@id":"https:\/\/enterpriseam.com\/ksa\/2026\/06\/17\/biotech-firms-weigh-up-listings-and-takeovers-amid-fierce-demand\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/enterpriseam.com\/ksa\/"},{"@type":"ListItem","position":2,"name":"Biotech firms weigh up listings and takeovers amid fierce demand"}]},{"@type":"WebSite","@id":"https:\/\/enterpriseam.com\/ksa\/#website","url":"https:\/\/enterpriseam.com\/ksa\/","name":"KSA","description":"The State of the Nation","publisher":{"@id":"https:\/\/enterpriseam.com\/ksa\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/enterpriseam.com\/ksa\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/enterpriseam.com\/ksa\/#organization","name":"KSA","url":"https:\/\/enterpriseam.com\/ksa\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/ksa\/#\/schema\/logo\/image\/","url":"https:\/\/ent.news\/internal\/42482.svg","contentUrl":"https:\/\/ent.news\/internal\/42482.svg","caption":"KSA"},"image":{"@id":"https:\/\/enterpriseam.com\/ksa\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/enterpriseam.com\/ksa\/#\/schema\/person\/ca597032db7e4db868359c123cec256d","name":"enterpriseam admin","sameAs":["http:\/\/enterpriseam.testing.projectsarea.com"],"url":"https:\/\/enterpriseam.com\/ksa\/author\/enterpriseam\/"}]}},"featured_image_src":"https:\/\/i0.wp.com\/ent.news\/2026\/6\/977.jpg?resize=600%2C400&ssl=1","featured_image_src_square":"https:\/\/i0.wp.com\/ent.news\/2026\/6\/977.jpg?resize=600%2C600&ssl=1","author_info":{"display_name":"enterpriseam admin","author_link":"https:\/\/enterpriseam.com\/ksa\/author\/enterpriseam\/"},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/ent.news\/2026\/6\/977.jpg?fit=%2C&ssl=1","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/enterpriseam.com\/ksa\/wp-json\/wp\/v2\/posts\/110296","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/enterpriseam.com\/ksa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/enterpriseam.com\/ksa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/ksa\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/ksa\/wp-json\/wp\/v2\/comments?post=110296"}],"version-history":[{"count":1,"href":"https:\/\/enterpriseam.com\/ksa\/wp-json\/wp\/v2\/posts\/110296\/revisions"}],"predecessor-version":[{"id":110327,"href":"https:\/\/enterpriseam.com\/ksa\/wp-json\/wp\/v2\/posts\/110296\/revisions\/110327"}],"acf:post":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/ksa\/wp-json\/wp\/v2\/issue\/110277"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/ksa\/wp-json\/wp\/v2\/media\/110297"}],"wp:attachment":[{"href":"https:\/\/enterpriseam.com\/ksa\/wp-json\/wp\/v2\/media?parent=110296"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/enterpriseam.com\/ksa\/wp-json\/wp\/v2\/categories?post=110296"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/enterpriseam.com\/ksa\/wp-json\/wp\/v2\/tags?post=110296"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/enterpriseam.com\/ksa\/wp-json\/wp\/v2\/brand?post=110296"},{"taxonomy":"newspack_spnsrs_tax","embeddable":true,"href":"https:\/\/enterpriseam.com\/ksa\/wp-json\/wp\/v2\/newspack_spnsrs_tax?post=110296"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}